China Resources Pharmaceutical Group Ltd
HKEX:3320
Intrinsic Value
The intrinsic value of one China Resources Pharmaceutical Group Ltd stock under the Base Case scenario is 15.31 HKD. Compared to the current market price of 4.87 HKD, China Resources Pharmaceutical Group Ltd is Undervalued by 68%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
China Resources Pharmaceutical Group Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
China Resources Pharmaceutical Group Ltd
Balance Sheet Decomposition
China Resources Pharmaceutical Group Ltd
Current Assets | 185.8B |
Cash & Short-Term Investments | 44.6B |
Receivables | 95.4B |
Other Current Assets | 45.8B |
Non-Current Assets | 71.9B |
Long-Term Investments | 7.8B |
PP&E | 25.9B |
Intangibles | 30.9B |
Other Non-Current Assets | 7.3B |
Free Cash Flow Analysis
China Resources Pharmaceutical Group Ltd
HKD | |
Free Cash Flow | HKD |
Earnings Waterfall
China Resources Pharmaceutical Group Ltd
Revenue
|
257.7B
HKD
|
Cost of Revenue
|
-217B
HKD
|
Gross Profit
|
40.7B
HKD
|
Operating Expenses
|
-27.7B
HKD
|
Operating Income
|
13B
HKD
|
Other Expenses
|
-9.7B
HKD
|
Net Income
|
3.4B
HKD
|
Profitability Score
Profitability Due Diligence
China Resources Pharmaceutical Group Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
China Resources Pharmaceutical Group Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
China Resources Pharmaceutical Group Ltd's solvency score is 47/100. The higher the solvency score, the more solvent the company is.
Score
China Resources Pharmaceutical Group Ltd's solvency score is 47/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
China Resources Pharmaceutical Group Ltd
According to Wall Street analysts, the average 1-year price target for China Resources Pharmaceutical Group Ltd is 7.16 HKD with a low forecast of 5.96 HKD and a high forecast of 9.03 HKD.
Dividends
Current shareholder yield for China Resources Pharmaceutical Group Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one China Resources Pharmaceutical Group Ltd stock under the Base Case scenario is 15.31 HKD.
Compared to the current market price of 4.87 HKD, China Resources Pharmaceutical Group Ltd is Undervalued by 68%.